Global Biosimilar Drug Market Research Report Forecast 2017 to 2022

July 2017 | 121 pages | ID: GA1DC773371EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Global Biosimilar Drug Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Biosimilar Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Biosimilar Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global Biosimilar Drug Market: Regional Segment Analysis
North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:
CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius
company 5
company 6
company 7
company 8
company 9

Global Biosimilar Drug Market: Product Segment Analysis
Injection
Tablets
Others


Global Biosimilar Drug Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 BIOSIMILAR DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Biosimilar Drug
1.2 Biosimilar Drug Market Segmentation by Type
  1.2.1 Global Production Market Share of Biosimilar Drug by Type in 2016
  1.2.1 Injection
  1.2.2 Tablets
  1.2.3 Others
1.3 Biosimilar Drug Market Segmentation by Application
  1.3.1 Biosimilar Drug Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Biosimilar Drug Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Biosimilar Drug (2012-2022)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON BIOSIMILAR DRUG INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL BIOSIMILAR DRUG MARKET COMPETITION BY MANUFACTURERS

3.1 Global Biosimilar Drug Production and Share by Manufacturers (2015 and 2016)
3.2 Global Biosimilar Drug Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Biosimilar Drug Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Biosimilar Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 Biosimilar Drug Market Competitive Situation and Trends
  3.5.1 Biosimilar Drug Market Concentration Rate
  3.5.2 Biosimilar Drug Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL BIOSIMILAR DRUG PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

4.1 Global Biosimilar Drug Production by Region (2012-2017)
4.2 Global Biosimilar Drug Production Market Share by Region (2012-2017)
4.3 Global Biosimilar Drug Revenue (Value) and Market Share by Region (2012-2017)
4.4 Global Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.5 North America Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.6 Europe Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.7 China Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.8 Japan Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.9 Southeast Asia Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
4.10 India Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)

CHAPTER 5 GLOBAL BIOSIMILAR DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

5.1 Global Biosimilar Drug Consumption by Regions (2012-2017)
5.2 North America Biosimilar Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.3 Europe Biosimilar Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.4 China Biosimilar Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.5 Japan Biosimilar Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.6 Southeast Asia Biosimilar Drug Production, Consumption, Export, Import by Regions (2012-2017)
5.7 India Biosimilar Drug Production, Consumption, Export, Import by Regions (2012-2017)

CHAPTER 6 GLOBAL BIOSIMILAR DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Biosimilar Drug Production and Market Share by Type (2012-2017)
6.2 Global Biosimilar Drug Revenue and Market Share by Type (2012-2017)
6.3 Global Biosimilar Drug Price by Type (2012-2017)
6.4 Global Biosimilar Drug Production Growth by Type (2012-2017)

CHAPTER 7 GLOBAL BIOSIMILAR DRUG MARKET ANALYSIS BY APPLICATION

7.1 Global Biosimilar Drug Consumption and Market Share by Application (2012-2017)
7.2 Global Biosimilar Drug Consumption Growth Rate by Application (2012-2017)
7.3 Market Drivers and Opportunities
  7.3.1 Potential Applications
  7.3.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL BIOSIMILAR DRUG MANUFACTURERS ANALYSIS

8.1 CP Guojian Pharma
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 Biotech Pharma
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Celgen Pharma
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 Henlius
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 company
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 company
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 company
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 company
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 company
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

CHAPTER 9 BIOSIMILAR DRUG MANUFACTURING COST ANALYSIS

9.1 Biosimilar Drug Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Biosimilar Drug

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Biosimilar Drug Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2016
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL BIOSIMILAR DRUG MARKET FORECAST (2017-2022)

13.1 Global Biosimilar Drug Production, Revenue Forecast (2017-2022)
13.2 Global Biosimilar Drug Production, Consumption Forecast by Regions (2017-2022)
13.3 Global Biosimilar Drug Production Forecast by Type (2017-2022)
13.4 Global Biosimilar Drug Consumption Forecast by Application (2017-2022)
13.5 Biosimilar Drug Price Forecast (2017-2022)

CHAPTER 14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Biosimilar Drug
Figure Global Production Market Share of Biosimilar Drug by Type in 2016
Table Biosimilar Drug Consumption Market Share by Application in 2016
Figure North America Biosimilar Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biosimilar Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Biosimilar Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Biosimilar Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Biosimilar Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Biosimilar Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Biosimilar Drug Revenue (Million UDS) and Growth Rate (2012-2022)
Table Global Biosimilar Drug Capacity of Key Manufacturers (2015 and 2016)
Table Global Biosimilar Drug Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Biosimilar Drug Capacity of Key Manufacturers in 2015
Figure Global Biosimilar Drug Capacity of Key Manufacturers in 2016
Table Global Biosimilar Drug Production of Key Manufacturers (2015 and 2016)
Table Global Biosimilar Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Biosimilar Drug Production Share by Manufacturers
Figure 2016 Biosimilar Drug Production Share by Manufacturers
Table Global Biosimilar Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Biosimilar Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Biosimilar Drug Revenue Share by Manufacturers
Table 2016 Global Biosimilar Drug Revenue Share by Manufacturers
Table Global Market Biosimilar Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Biosimilar Drug Average Price of Key Manufacturers in 2016
Table Manufacturers Biosimilar Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Biosimilar Drug Product Type
Figure Biosimilar Drug Market Share of Top 3 Manufacturers
Figure Biosimilar Drug Market Share of Top 5 Manufacturers
Table Global Biosimilar Drug Capacity by Regions (2012-2017)
Figure Global Biosimilar Drug Capacity Market Share by Regions (2012-2017)
Figure Global Biosimilar Drug Capacity Market Share by Regions (2012-2017)
Figure 2015 Global Biosimilar Drug Capacity Market Share by Regions
Table Global Biosimilar Drug Production by Regions (2012-2017)
Figure Global Biosimilar Drug Production and Market Share by Regions (2012-2017)
Figure Global Biosimilar Drug Production Market Share by Regions (2012-2017)
Figure 2015 Global Biosimilar Drug Production Market Share by Regions
Table Global Biosimilar Drug Revenue by Regions (2012-2017)
Table Global Biosimilar Drug Revenue Market Share by Regions (2012-2017)
Table 2015 Global Biosimilar Drug Revenue Market Share by Regions
Table Global Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table China Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table India Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Biosimilar Drug Consumption Market by Regions (2012-2017)
Table Global Biosimilar Drug Consumption Market Share by Regions (2012-2017)
Figure Global Biosimilar Drug Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Biosimilar Drug Consumption Market Share by Regions
Table North America Biosimilar Drug Production, Consumption, Import & Export (2012-2017)
Table Europe Biosimilar Drug Production, Consumption, Import & Export (2012-2017)
Table China Biosimilar Drug Production, Consumption, Import & Export (2012-2017)
Table Japan Biosimilar Drug Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Biosimilar Drug Production, Consumption, Import & Export (2012-2017)
Table India Biosimilar Drug Production, Consumption, Import & Export (2012-2017)
Table Global Biosimilar Drug Production by Type (2012-2017)
Table Global Biosimilar Drug Production Share by Type (2012-2017)
Figure Production Market Share of Biosimilar Drug by Type (2012-2017)
Figure 2015 Production Market Share of Biosimilar Drug by Type
Table Global Biosimilar Drug Revenue by Type (2012-2017)
Table Global Biosimilar Drug Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Biosimilar Drug by Type (2012-2017)
Figure 2015 Revenue Market Share of Biosimilar Drug by Type
Table Global Biosimilar Drug Price by Type (2012-2017)
Figure Global Biosimilar Drug Production Growth by Type (2012-2017)
Table Global Biosimilar Drug Consumption by Application (2012-2017)
Table Global Biosimilar Drug Consumption Market Share by Application (2012-2017)
Figure Global Biosimilar Drug Consumption Market Share by Application in 2015
Table Global Biosimilar Drug Consumption Growth Rate by Application (2012-2017)
Figure Global Biosimilar Drug Consumption Growth Rate by Application (2012-2017)
Table CP Guojian Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table CP Guojian Pharma Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table CP Guojian Pharma Biosimilar Drug Market Share (2012-2017)
Table Biotech Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Biotech Pharma Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Biotech Pharma Biosimilar Drug Market Share (2012-2017)
Table Celgen Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Celgen Pharma Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Celgen Pharma Biosimilar Drug Market Share (2012-2017)
Table Henlius Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Henlius Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Henlius Biosimilar Drug Market Share (2012-2017)
Table company 5 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 5 Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table company 5 Biosimilar Drug Market Share (2012-2017)
Table company 6 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 6 Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table company 6 Biosimilar Drug Market Share (2012-2017)
Table company 7 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 7 Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table company 7 Biosimilar Drug Market Share (2012-2017)
Table company 8 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 8 Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table company 8 Biosimilar Drug Market Share (2012-2017)
Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 9 Biosimilar Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table company 9 Biosimilar Drug Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Drug
Figure Manufacturing Process Analysis of Biosimilar Drug
Figure Biosimilar Drug Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2016
Table Major Buyers of Biosimilar Drug
Table Distributors/Traders List
Figure Global Biosimilar Drug Production and Growth Rate Forecast (2017-2022)
Figure Global Biosimilar Drug Revenue and Growth Rate Forecast (2017-2022)
Table Global Biosimilar Drug Production Forecast by Regions (2017-2022)
Table Global Biosimilar Drug Consumption Forecast by Regions (2017-2022)
Table Global Biosimilar Drug Production Forecast by Type (2017-2022)
Table Global Biosimilar Drug Consumption Forecast by Application (2017-2022)

COMPANIES MENTIONED

CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius